Researchers at Duke, Emory and University of Texas Health Science Center to Study Effects of VNS Therapy on the Brain

HOUSTON, May 23 /PRNewswire-FirstCall/ -- Cyberonics, Inc. today announced the initiation of three important studies designed to add to the growing body of evidence supporting the unique mechanism of action of VNS Therapy(TM) in treatment-resistant depression (TRD). The studies, taking place at Duke University Medical Center, Emory University and University of Texas Health Science Center, are ...

To read the rest of this article click here to take a free trial